Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
F Fais, … , M Ferrarini, N Chiorazzi
F Fais, … , M Ferrarini, N Chiorazzi
Published October 15, 1998
Citation Information: J Clin Invest. 1998;102(8):1515-1525. https://doi.org/10.1172/JCI3009.
View: Text | PDF
Research Article Article has an altmetric score of 9

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

  • Text
  • PDF
Abstract

To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.

Authors

F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1981 Total
Citations: 2 7 9 10 28 16 11 17 25 18 27 25 48 29 37 31 33 30 36 37 33 35 32 29 30 26 12 1 674
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2018 (17)

Title and authors Publication Year
Combined Influence of B-Cell Receptor Rearrangement and Somatic Hypermutation on B-Cell Class-Switch Fate in Health and in Chronic Lymphocytic Leukemia
VN Petrova, L Muir, PF McKay, GS Vassiliou, KG Smith, PA Lyons, CA Russell, CA Anderson, P Kellam, RJ Bashford-Rogers
Frontiers in immunology 2018
Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy
JA Burger, S OBrien
Nature Reviews Clinical Oncology 2018
Chronic Lymphocytic Leukemia–Derived IL-10 Suppresses Antitumor Immunity
SS Alhakeem, MK McKenna, KZ Oben, SK Noothi, JR Rivas, GC Hildebrandt, RA Fleischman, VM Rangnekar, N Muthusamy, S Bondada
Journal of immunology (Baltimore, Md. : 1950) 2018
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
G Blanco, A Vardi, A Puiggros, A Gómez-Llonín, M Muro, M Rodríguez-Rivera, E Stalika, E Abella, E Gimeno, M López-Sánchez, A Senín, X Calvo, P Abrisqueta, F Bosch, A Ferrer, K Stamatopoulos, B Espinet
OncoImmunology 2018
Assessing human B cell repertoire diversity and convergence
K Imkeller, H Wardemann
Immunological Reviews 2018
The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia
E ten Hacken, M Gounari, P Ghia, JA Burger
Leukemia 2018
Double sword role of EZH2 in leukemia
S Safaei, B Baradaran, MF Hagh, MR Alivand, M Talebi, T Gharibi, S Solali
Biomedicine & Pharmacotherapy 2018
Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia
ED Rout, RC Burnett, JD Labadie, JA Yoshimoto, AC Avery, S Bondada
PloS one 2018
Strategies to overcome resistance mutations of Bruton's tyrosine kinase inhibitor ibrutinib
L Liu, B Shi, X Wang, H Xiang
Future Medicinal Chemistry 2018
Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones
SV Meeren, B Heyrman, W Renmans, M Bakkus, B Maes, HD Raeve, R Schots, K Jochmans
Annals of Hematology 2018
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, H Döhner, P Hillmen, M Keating, E Montserrat, N Chiorazzi, S Stilgenbauer, KR Rai, JC Byrd, B Eichhorst, S OBrien, T Robak, JF Seymour, TJ Kipps
Blood 2018
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent
A Rigo, I Ferrarini, A Bonalumi, C Tecchio, A Montresor, C Laudanna, F Vinante
Oncotarget 2018
A phase 2 study of ofatumumab (Arzerra ® ) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*
CI Chen, H Paul, LW Le, EN Wei, S Snitzler, T Wang, O Levina, S Kakar, A Lau, M Queau, JB Johnston, DA Smith, S Trudel
Leukemia & Lymphoma 2018
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases
F Morabito, TD Shanafelt, M Gentile, G Reda, FR Mauro, D Rossi, ND Renzo, S Molica, F Angrilli, A Chiarenza, G Cutrona, KG Chaffee, SA Parikh, G Tripepi, G D'Arrigo, E Vigna, AG Recchia, A Cortelezzi, G Gaidano, FD Raimondo, F Fais, R Foà, A Neri, M Ferrarini
American Journal of Hematology 2018
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
LV Abruzzo, CD Herling, GA Calin, C Oakes, LL Barron, HE Banks, V Katju, MJ Keating, KR Coombes
Haematologica 2018
A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
CI Chen, H Paul, S Snitzler, S Kakar, LW Le, EN Wei, A Lau, JB Johnston, SB Gibson, M Queau, D Spaner, D Croucher, B Sherry, S Trudel
Leukemia & Lymphoma 2018
Pathologie: Knochenmark, Lymphatisches System, Milz, Thymus
HK Müller-Hermelink, HH Kreipe
2018

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 19 patents
291 readers on Mendeley
See more details